JL

Jennifer Levin Carter

Founder of Medzown

Boston, Massachusetts

Overview 

Jennifer Levin Carter is an accomplished professional with extensive experience in precision medicine management, currently serving as the Founder and CEO of Medzown and a Venture Partner at Sandbox Industries. Her career highlights include co-founding Xsphera Biosciences Inc and serving on the Board of Directors for OncoCyte Corp. She holds an impressive educational background with an MBA from MIT Sloan School of Management, an MD from Harvard Medical School, and a Masters of Public Health from Harvard T.H. Chan School of Public Health, along with a Bachelor of Science from Yale University.

Work Experience 

  • Founder and CEO

    2023 - Current

    Medzown is Precision Medicine Management at Scale. We use advanced analytics and deep expertise to bridge the gap between patients and treatments like immunotherapies, targeted therapies, cell and gene therapies, and clinical trials. At the same time, we deliver exceptional return on investment for payers, providers, and pharma.

Medzown is a medicine company that offers analytics services for immunotherapy and targeted therapy.

  • Founder and CEO

    2023

  • Venture Partner

    2021

    Sandbox invests in technologies that drive lasting change in human livelihood and transform healthcare, sustainability and insurance & financial services. Sandbox also provides innovation consulting through Sandbox Advisors. Sandbox Clinical Ventures focuses on accelerating clinical innovation by investing in companies with transformative diagnostic, device and lab technologies. We bring together key stakeholders across the strategic and investment landscape to back companies that can improve the health of populations, reimagine the experience of care, and bend the cost curve.

Sandbox bridges the gap between startups and corporations in three ways: strategic venture funds, accelerators, and consulting services.

  • Senior Strategic Advisor

    2020

Drumroll AI is a robust data science platform that harnesses the power of AI and advanced algorithms to enable users to analyze data faster.

  • Co-founder, Board Member

    2019

Xsphera Biosciences is a biotechnology startup that focuses on delivering functional, precision immuno-oncology solutions.

Raised $17,600,067.00 from Aquila Capital Partners.

  • Board of Directors

    2018

  • Member, Directors Advisory Board

    2013

  • Board Member, Board Of Directors

    2020 - 2023

  • Managing Director

    2021 - 2023

    The Blue Venture Fund is a unique collaboration among Blue Cross Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association (BCBSA), and Sandbox, to which thirty-five BCBS companies have committed approximately $900 million across four funds. The Blue Venture Fund invests in promising emerging companies of strategic relevance to Blue Cross and/or Blue Shield companies and provides the portfolio with access to BCBS companies to deploy innovation at scale.  Sandbox is an independent company that provides healthcare-related investment management exclusively for the Blue Venture Fund.

The Blue Venture Fund is a strategic investment vehicle that aims to foster innovation within the healthcare system.

  • Board Member and Senior Advisor

    2020 - 2022

    Acquired by InTandem

eCaring Home Care Software offers a SaaS solution for scheduling, delivering, and billing home care services.

Raised $3,500,000.00 from Stephen Jackson and Ascent Biomedical Ventures.

Articles About Jennifer Levin

Relevant Websites